Stifel Financial Corp Instil Bio, Inc. Transaction History

Stifel Financial Corp

  • $93.2 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.48 - $5.33 $2,400 - $26,650
5,000 Added 43.48%
16,500 $10,000
Q3 2021

Nov 15, 2021
BUY
$15.05 - $23.28 $173,075 - $267,720
11,500 New
11,500 $206,000

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email